US · Healthcare

XBiotech Inc (XBIT)

Biotechnology

XBiotech Inc (XBIT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XBIT

P/E ratio

25.00

XBiotech Inc (XBIT) — FAQ

What is XBIT's P/E ratio?

The price-to-earnings (P/E) ratio for XBiotech Inc (XBIT) is 25.00 (data as of 2026-05-23).

Does XBiotech Inc pay a dividend?

Dividend yield is not available in the current snapshot for XBiotech Inc (XBIT). Check the MyAverix Finance app for the latest dividend data.

What sector is XBiotech Inc in?

XBiotech Inc (XBIT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is XBIT listed on?

XBIT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)